Functional Magnetic Resonance Imaging (fMRI) data acquired during semantic and phonological verbal fluency tasks were shown to allow for diagnosis of Major Depressive Disorder (MDD) with 90% accuracy [1] . We demonstrate that the activation in the brain areas selected through the so-called group LASSO algorithm [2] applied in [1] significantly correlate with symptoms as well as other commonly MDD associated characteristics.
trols underwent a detailed interview, where following common MDD scores were assessed: BDI2, PHQ-9, HRSD17, GAF, CATS, LES, PANAS, STAI (for abbreviations see [3] ).
fMRI data acquired during a phonological and a semantic verbal fluency task were processed in conventional way and the activation-maps of all subjects subjected to the group LASSO algorithm [1] . This resulted in a weight map for each verbal fluency task. The mean brain activation during the respective tasks was calculated for each region of interest indicated in the maps. Finally, the correlation between each region of interest and the interview scores was evaluated.
Five ROIs located in precentral cortex, pars triangularis, inferior frontal operculum, insula and postcentral gyrus of the left hemisphere showed significant correlation with the interview data (p<0.001).
Correlated MDD characteristics were several depression severity measures (BDI, PHQ9, GAF), but also diathesis (CATS and negative LES) and specific symptoms (SHAPS, PANAS and STAI). All of the above, except for LES showed significant correlation with the post central gyrus.
The results elucidate the relation of the brain areas relevant for the classification model evaluated in [1] with depression severity, diathesis and certain MDD characteristics. Even though causality remains to be investigated, the results give insight into how integrative effects might finally induce depression. Efficacy, safety, and cumulative relapse and remission were studied over the following 6 years.
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Results: 94 patients completed 3 years treatment. All were free of panic attacks since at least one year before undergoing tapered drug withdrawal. In annually studied patients the relapse rates were similar after the 3 treatments with a marginal advantage of clonazepam over the combination and paroxetine at the first year after drug withdrawal. Cumulative relapses rate were 41%, 77%, and 94% at years 1, 4, and 6. 90% of the annually followed patients were during the 6 years of follow up in average in remission (partial: 54%, full: 36%); 73% were PA-free, 91% had a GCI-S score of 1, and 39% HAMA scores of 5-10; 33% needed drug treatment in each follow-up year. Both treatments displayed similarly high efficacy, but clonazepam was better tolerated. Results in patients studied at the end of follow-up only were similar, but somewhat less favorable: 88% were in remission, 72% were PA-free, 62% had a CGI-S score of 1 and 30% a HAMA of 5-10, with 39% needing PD treatment. Conclusion: PD is a chronic disorder, with many patients relapsing despite being asymptomatic at least one year after 3 years treatment. Paroxetine and clonazepam were associated with similar long-term prognoses but clonazepam was better tolerated.
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